Skip to content
Clinical Trials – home
AustriaBack to Austria

Clinical trials in Stockerau – page 20

880 clinical trials in Stockerau, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Stockerau at a glance
880
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

880 trials in Stockerau

Open in trial search

Study of Piperacillin/Tazobactam and Levofloxacin for Patients with COPD or Cystic Fibrosis

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Piperacillin
  • Sponsor:Medical University Of Vienna

Hyperlipidaemia

Recruiting

Study on the Effects of Alirocumab and Drug Combination on Hyperlipidemia in Patients

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Alirocumab
  • Sponsor:Medical University Of Vienna

Study of drug combination therapy for patients with recurrent and primary refractory Ewing Sarcoma

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anhydrous Docetaxel
  • Sponsor:The University Of Birmingham

Meningioma

Recruiting

Study of Lutetium (177Lu) Oxodotreotide for Patients with Recurrent Meningioma Without Surgery or Radiotherapy Options

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europeenne Pour La Recherche Et Le Traitement Du Cancer European Organi

Hepatic cirrhosis+1

Recruiting

Study on Norfloxacin for Reducing Portal Hypertension in Patients with Decompensated Cirrhosis

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Norfloxacin
  • Sponsor:Medical University Of Vienna

Study on the Effects of Intracochlear Triamcinolone Acetonide for Patients with Persistent Sudden Sensorineural Hearing Loss After Unsuccessful Conservative Treatment

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Triamcinolone Acetonide
  • Sponsor:Medical University Of Vienna

Study on the Effectiveness and Safety of Fosmanogepix Compared to Caspofungin and Fluconazole for Adults with Candidemia or Invasive Candidiasis

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Caspofungin
  • Sponsor:Basilea Pharmaceutica International AG Allschwil

Study of Ziftomenib with Chemotherapy for Children with Relapsed or Refractory Acute Leukemia

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Cytarabine
  • Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Study on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Elacestrant
  • Sponsor:Medica Scientia Innovation Research S.L.

Study Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Pfizer Inc.

Crohn's disease

Recruiting

Study of Mirikizumab for Children with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Osteoarthritis

Recruiting

Study on Shortened Anticoagulation with Rivaroxaban for Blood Clot Prevention in Patients Undergoing Hip Replacement Surgery

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Rivaroxaban
  • Sponsor:Universitatsmedizin der Johannes Gutenberg-Universitat Mainz KöR

Other cities in Austria

The busiest research cities in the country

All 48 cities in Austria

Clinical research in Stockerau

What the registry says about research in the country

01 Metabolic Health Studies

Innovative research focusing on obesity and cardiovascular health, examining new therapeutic approaches for weight management and associated cardiovascular risks.

  • Cardiovascular Safety Assessment
  • Weight Management
  • Metabolic Disease Prevention

Studies aim to evaluate cardiovascular outcomes in individuals with overweight or obesity conditions.

02 Autoimmune Research

Clinical investigations targeting Sjögren's Syndrome, evaluating novel biological treatments to improve patient outcomes and disease management.

  • Disease Activity Assessment
  • Immunological Response
  • Symptom Management

Research focuses on measuring treatment efficacy through standardized disease activity scores.

03 Therapeutic Innovations

Advanced clinical research examining novel therapeutic compounds for chronic conditions, with emphasis on safety and efficacy measurements.

  • Drug Safety Profiles
  • Treatment Effectiveness
  • Patient Response Monitoring

Studies incorporate comprehensive safety monitoring and outcome assessment protocols.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.